BIO-Europe Spring 2014: Interview with Mike Crowley, Genentech

April 8, 2014
Genentech is known for its oncology franchise, but the company also has a significant footprint in immunology and an emerging infectious disease portfolio. Mike Crowley sheds light on his business development focus for increasing these lines of business. For more information on BIO-Europe Spring, visit our webpage: http://www.ebdgroup.com/bes/index.php Please view the rest of the video at http://www.partnering360.com/insight/showroom/id/491
Previous Video
BIO-Europe® is where great biotech partnerships begin
BIO-Europe® is where great biotech partnerships begin

BIO-Europe 2015® | November 2-4 in Munich, Germany | http://www.ebdgroup.com/bioeurope BIO-Europe® is Euro...

Next Video
BIO-Europe Spring: Interview with Matthew Durdy, Cell Therapy Catapult
BIO-Europe Spring: Interview with Matthew Durdy, Cell Therapy Catapult

Matthew Durdy, Chief Business Officer at Cell Therapy Catapult, discusses the role of cell-based therapies ...